Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
CIS001 Extension Study of Cyclosporine Inhalation Solution (CIS002)
This study has been terminated.
( Parent study CIS001 was completed )
Study NCT00938236 Information provided by APT Pharmaceuticals, Inc.
First Received on July 9, 2009. Last Updated on September 13, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Sponsors listed in this trial
APT Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers